Cancer cell lipid class homeostasis is altered under nutrient-deprivation but stable under hypoxia
FAs to fuel proliferation, growth, and migration. Taken together, these findings are compatible with the notion that both lipogenesis and lipolysis may be utilized by cancer cells to fulfill their FA requirements.
The mode of FA acquisition -via de novo synthesis or uptake-may significantly affect the lipidomic profiles of cancer cells. Mammalian cells have a limited ability to synthesize polyunsaturated fatty acids de novo, as they lack the Δ lipid peroxidation than polyunsaturated acyl chains, de novo synthesis was proposed to make cancer cells more resistant to oxidative stress-induced cell death (20) . Moreover, as saturated lipids pack more densely their increased levels alter lateral and transverse membrane dynamics that may limit the uptake of drugs, making the cancer cells more resistant to therapy (20) . Hence, the balance between FA synthesis and uptake may have important therapeutic implications.
Cancer cells are shown to modify balances of FA synthesis and uptake under metabolic stress, i.e.
induced by oxygen and nutrient deprivation (3, 21) . This metabolic flexibility is particularly important for cancer cells within solid tumors that are exposed to oxygen-and nutrient-gradients depending on their distance from the nearest blood vessels. The inefficient vascularization limits access of various nutrientssuch as amino acids, sugars and lipids-to tumor tissues. The effect of oxygen/nutrient deprivation on leukemic cells was presumed to be inconsequential and remained long overlooked. This view is also being revised and hypoxia has been shown to influence leukemic cell proliferation, differentiation, and resistance to chemotherapy (reviewed in (22)). It will also be interesting to study the impact of oxygen/nutrient deprivation on metabolic pathways in leukemic cells.
To date, the effect of metabolic stress on lipid metabolism in cancer cells appears inconsistent. Herein, to study the complex interplay between metabolic stress and lipid metabolism in cancer cells, we selected a biologically diverse panel of cancer cell lines -three leukemia cell lines (to cover intra-group variance), two colon cancer cell lines and one lung cancer cell line. We were mainly interested in studying the impact of physiologically relevant metabolic stress on lipid metabolism in cancer cells. To achieve that cancer cells were cultivated under nutrient-deprivation and hypoxia -that closely mimics the in vivo conditions. The expression of relevant markers was assessed to study the relative dependence of cancer cells on de novo lipid synthesis versus lipid uptake/degradation pathways under metabolic stress.
In order to gain more systematic insight on the effects of metabolic stress on lipidomic profiles we performed a broad lipidomics assay comprising 244 lipids from six major classes. To this end we identified multiple changes in lipidomic profiles of cancer cells cultivated under low-serum or lipiddeficient conditions. Under hypoxic stress cancer cells displayed alterations in cell proliferation rates and expression profiles of various lipid metabolism associated genes. Interestingly, no robust changes were observed in lipidomic profiles of hypoxic cancer cells indicating that the cells maintain lipid class homeostasis.
Materials and Methods

Cell culture and treatments
The SW480, SW620, A549, KG1, KCL22 and KU812 cell lines were maintained in DMEM (Gibco, 31966-021) or RPMI 1640 medium (Gibco, 61870-010) media supplemented with 10% fetal bovine serum (FBS) (Sigma, F75240) and penicillin-streptomycin solution (Corning, . Cell cultures were maintained in the atmosphere of 5% CO 2 and 37°C. For all experiments cells were initially seeded and cultivated in normal media for 24 hours. Then to induce metabolic stress media and/or growth conditions were respectively changed and cells were cultivated for additional 48 hours under either one of the following condition: lipoprotein deficient medium (LPDS serum), low-serum (LS) medium (2% serum), hypoxia (2% O2), or hypoxia in combination with LS medium. For lipoprotein deficient conditions the media were supplemented with lipoprotein deficient serum (LPDS) that was purchased from Merck (LP4) and used according to manufacturer's guidelines. For determining the cells number cells were stained with trypan blue and counted using Countess® automated cell counter (Invitrogen).
Cell lines were commercially authenticated (Eurofins, Germany) and mycoplasma tested prior to submission of this manuscript.
Quantitative RT-PCR
For quantitative RT-PCR, total RNA was extracted from cell pellets using Quick-RNA™ MiniPrep Plus (Zymo Research). All RNA samples were reverse-transcribed into cDNA using SuperScript™ III Reverse Transcriptase (Thermo Scientific, 18080093) and Oligo(dT)18 Primers (Thermo Scientific, SO131).
Quantitative PCR was performed using a TaqMan™ Gene Expression Master Mix (4369016, Applied Biosystems) via StepOne Real-Time PCR Systems (Applied Biosystems). The TaqMan Gene Expression assays used were Hs01005622_m1 (fatty acid synthase, FASN), Hs00168352_m1 (3-hydroxy-3-methylglutaryl-CoA reductase, HMGCR), Hs00996004_m1 (monoglyceride lipase, MGLL), Hs00173425_m1 (lipoprotein lipase, LPL) and Hs00354519_m1 (CD36). The expression of each gene was normalized to the expression of GADPH (Hs02786624_g1).
Lipid Extractions
First, the cell pellets were washed with 0.5 mL 0.9% NaCl. For extraction of lipids the pellets were resuspended in 1 ml ice-cold MMC (1:1:1 v/v/v methanol/MTBE/chloroform). Samples were incubated on an ultrasonic bath for two minutes. Phase separation was induced by adding 300 μ L MS-grade water.
After 10 min incubation, the samples were centrifuged for 10 min at 1000 rpm and the upper (organic) phase was collected. Then 200 μ L of collected organic phase were dried in a vacuum rotator and stored at -20 °C until analysis.
Lipidomic Profiling
Dried sample extracts were reconstituted in 100 µL 2 
Statistical analysis
The differences between groups were analyzed by ANOVA or t-test (paired or unpaired), where Figure 1) .
All the leukemia cell lines had higher expression of both FASN and HMGCR in comparison to the adherent cell lines derived from solid tumor tissues. It reflects comparatively higher de novo lipid synthesis in leukemia cells.
The expression of lipolytic markers (LPL and MGLL) was also assessed for the selected cell line panel.
We observed consistent expression of LPL only in SW480 and KU812. The expression of MGLL was strikingly different among the selected cell lines with up to ~250-folds difference between SW620 and A549 ( Figure 1a) . Expression of CD36 -fatty acid uptake marker-was only detectable in KU812. These data indicate that the selected cell lines are significantly different in terms of baseline levels of lipid metabolism related transcripts.
0
Comparison of baseline lipidomic profiles of cancer cell lines
Next, we compared the baseline lipidomic profiles of the selected cell lines. To integrate the lipidomics data with gene expression profiles we determined the lipidomic profiles of the same samples that were used for qPCR analysis. Global lipidomic profiling using Liquid Chromatography-Mass Spectrometry (LC-MS) followed by automatic annotation using MS-Dial (v.2.72 (30)) allowed to detect 244 lipid compounds each present in at least 90% of all samples ( Table 1) showed decreased proliferation rates when cultivated in media containing lipoprotein-deficient serum (LPDS). KU812 and SW480 express LPL and CD36 proteins that are involved in lipolysis and uptake of extracellular fatty acids. Therefore, they might be more sensitive to LPDS medium. All cell lines except SW620 showed reduced proliferation rates under low-serum environment. Hypoxic conditions induced decreased proliferation rates in A549 and SW480. When cultivated under hypoxia in combination with low-serum medium all cell lines except SW620 displayed reduced proliferation rates.
It has been reported that cancer cell lines differentially regulate de novo lipid synthesis pathways under oxygen and/or nutrient deprivation (23) (24) (25) 28) . Here, we also observed differential impact of metabolic stress on expression of FASN and HMGCR. This data also indicates cell-type specific regulation of de novo lipid synthesis pathways under metabolic stress (Supplementary Figure 3) . mRNA levels of FASN and HMGCR under stress conditions also displayed highly positive correlation (R 2 =0.75; P <0.0001) (Supplementary Figure 4) . The expression of markers of lipid uptake/degradation (LPL, MGLL and CD36) was also differentially affected by metabolic stress (Supplementary Figure 3) .
Effect of metabolic stress on lipidomic profile of cancer cells
Next, we studied the effects of metabolic stress on lipidomic profiles of cancer cells. Previous studies have already shown various stress-related effects on individual lipid-moieties. Our broad lipidomic assay allowed us to assess the impact of metabolic stress on robust averages of broader lipid-classes, providing a more holistic overview of cancer cell lipidomic profiles. subspecies. Some of these changes were in line with published data (27, 31).
Discussion
The presented work aimed to determine the impact of metabolic stress on expression of selected lipid metabolism genes, lipidomic profiles and cell proliferation in biologically diverse cancer cells. We observed that under metabolic stress different cancer cell lines showed differential expression of markers for de novo lipid synthesis and lipid-uptake/degradation. These data confirm previous works that showed cell-type specific regulation of lipid metabolism under oxygen and nutrient-deprivation (28). Careful scrutiny of literature revealed that previous works not only used different cell line models but also applied different cell culture conditions. For instance, differences in methods for inducing hypoxia or duration/severity of hypoxia were noted. These differences could have introduced variations in the data. Meticulous literature survey revealed differences in cell culture methods among previous studies that may also lead to contradictory evidence. For instance; cells were serum-starved prior to hypoxia-induction (31), hypoxia was applied in combination with nutrient-deprivation (27) B r J C a n c e r 1 0 0 : 
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